Tech Company Financing Transactions

Intersect ENT Funding Round

On 6/5/2008, Intersect ENT raised $20 million in Series B funding from PTV Sciences, Kleiner Perkins Caufield & Byers and U.S. Venture Partners.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Medical Devices & Instruments

Mailing Address

1555 Adams Dr.
Menlo Park, CA 94025
USA

Phone

(650) 641-2100

Website

www.intersectent.com

Email Address

[email protected]

Overview

Intersect ENT's mission is to advance clinically proven therapy solutions that enable ear, nose, and throat (ENT) physicians to solve clinical challenges and improve the quality of life for patients.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Thomas West

        

Chief Financial Officer

Randy Meier

        

Chief Operating Officer

Christine Kowalski

        

VP - General Counsel

David Lehman

        

VP - Human Resources

Gwen Carscadden

        

VP - Sales

Robert Binney

        

Browse more venture capital transactions:

Prev: 6/5/2008: Kiptronic venture capital transaction
Next: 6/5/2008: Mithridion venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary